Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
CARsgen Announces the Publication of a Novel CAR-T Technology that Improves the Efficacy of CAR-T cells Against Solid Tumors without Requiring Preconditioned Lymphodepletion 2020-08-17 18:00
First HBV Patient Dosed in Phase IIa Clinical Trial of ASC22, a Subcutaneously Administered PD-L1 Antibody 2020-08-17 08:30
iHerb Announces Major Global Delivery Expansion 2020-08-17 08:29
China's First Trastuzumab Biosimilar Approved by NMPA 2020-08-17 08:00
Sai Life Sciences opens new, state-of-the-art Research & Technology Centre in Hyderabad 2020-08-17 08:00
Ascentage Pharma Becomes a Constituent of Three Major Indexes Including Hang Seng Composite Index 2020-08-17 07:30
Memo Therapeutics AG and Northway Biotechpharma Collaborate on the Fast-Track Manufacturing of a SARS-CoV-2-Neutralizing Antibody for the Therapy of COVID-19 2020-08-15 08:36
Lee's Pharm Announced 2020 Interim Results Positive Profit Alert 2020-08-14 23:49
China Jo-Jo Drugstores Reports First Quarter 2021 Financial Results 2020-08-14 21:00
China Pharma Holdings, Inc. Reports Second Quarter 2020 Financial Results 2020-08-14 18:30
Family Mask Supports UNGC Leaders' Summit 2020 2020-08-14 15:30
Bushu Pharmaceuticals Announces Major Expansion Program 2020-08-14 14:00
Sinopharm Tech plans to purchase 337 tons Meltblown Fabric 2020-08-14 09:18
Violet Defense's UV Disinfection Technology Proven Up to 99.99% Effective Against Coronavirus 2020-08-14 08:04
Hankyung.com's introduces: "Seoul Made" PPE kits, targeting US Market 2020-08-14 08:00
Aquavit Pharmaceuticals, Inc. Secures Court Order on Compensatory Sanctions Against Counterfeiters for Contempt on Patent and Trademark Infringement Case 2020-08-14 02:32
Zai Lab Announces Financial Results for Six Months Ended June 30, 2020 and Corporate Updates 2020-08-13 22:38
AGC Biologics Enters into Partnership as a CDMO with Ono Pharmaceuticals to Manufacture Biopharmaceuticals at Clinical Development Stage 2020-08-13 21:00
ANTI-PD-1/CTLA-4 Bi-specific Antibody (AK104) of Akeso Granted FDA Fast Track Designation for Recurrent and Metastatic Cervical Cancer 2020-08-13 20:07
Ajinomoto Bio-Pharma Services Expands Small Molecule Manufacturing Capabilities at its India Facility 2020-08-13 20:06
1 738 739 740 741 742 1597